| 000 | 01270 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517202917.0 | ||
| 264 | 0 | _c20190117 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2018.01.048 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMansur, Rodrigo B | |
| 245 | 0 | 0 |
_aCognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists? _h[electronic resource] |
| 260 |
_bNeuropharmacology _c07 2018 |
||
| 300 |
_a335-342 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCognitive Dysfunction _xepidemiology |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide-1 Receptor _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetabolic Diseases _xepidemiology |
| 650 | 0 | 4 |
_aMood Disorders _xepidemiology |
| 650 | 0 | 4 | _aGlucagon-Like Peptide-1 Receptor Agonists |
| 700 | 1 | _aLee, Yena | |
| 700 | 1 | _aSubramaniapillai, Mehala | |
| 700 | 1 | _aBrietzke, Elisa | |
| 700 | 1 | _aMcIntyre, Roger S | |
| 773 | 0 |
_tNeuropharmacology _gvol. 136 _gno. Pt B _gp. 335-342 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2018.01.048 _zAvailable from publisher's website |
| 999 |
_c28123571 _d28123571 |
||